Dimensional Fund Advisors LP Grows Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Dimensional Fund Advisors LP boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 12.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,341,944 shares of the medical device company’s stock after buying an additional 148,500 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.67% of Cooper Companies worth $117,156,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Franklin Resources Inc. raised its position in shares of Cooper Companies by 1.2% during the 4th quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after acquiring an additional 41 shares in the last quarter. LRI Investments LLC lifted its position in shares of Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock worth $227,000 after buying an additional 112 shares during the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Cooper Companies by 0.8% in the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after buying an additional 118 shares in the last quarter. First Horizon Advisors Inc. grew its position in shares of Cooper Companies by 4.8% in the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock valued at $236,000 after buying an additional 125 shares during the last quarter. Finally, American International Group Inc. raised its stake in Cooper Companies by 1.0% during the 4th quarter. American International Group Inc. now owns 13,229 shares of the medical device company’s stock worth $5,006,000 after acquiring an additional 137 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on COO shares. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley upped their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

Cooper Companies Stock Down 0.5 %

Shares of NASDAQ:COO opened at $110.49 on Monday. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The firm’s 50-day simple moving average is $97.93 and its 200-day simple moving average is $95.45. The company has a market cap of $22.00 billion, a price-to-earnings ratio of 64.99, a PEG ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.84 EPS. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.66 earnings per share for the current year.

Insiders Place Their Bets

In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.